ATE179885T1 - Pharmazeutisches trägersystem, das definierte lipide enthält - Google Patents

Pharmazeutisches trägersystem, das definierte lipide enthält

Info

Publication number
ATE179885T1
ATE179885T1 AT93908232T AT93908232T ATE179885T1 AT E179885 T1 ATE179885 T1 AT E179885T1 AT 93908232 T AT93908232 T AT 93908232T AT 93908232 T AT93908232 T AT 93908232T AT E179885 T1 ATE179885 T1 AT E179885T1
Authority
AT
Austria
Prior art keywords
pct
carrier system
system containing
pharmaceutical carrier
lipid
Prior art date
Application number
AT93908232T
Other languages
English (en)
Inventor
Hakan Nyqvist
Gert Ragnarsson
Per Tingvall
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of ATE179885T1 publication Critical patent/ATE179885T1/de

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT93908232T 1992-03-27 1993-03-26 Pharmazeutisches trägersystem, das definierte lipide enthält ATE179885T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9200952A SE9200952D0 (sv) 1992-03-27 1992-03-27 Pharmaceutical carrier system containing defined lipids

Publications (1)

Publication Number Publication Date
ATE179885T1 true ATE179885T1 (de) 1999-05-15

Family

ID=20385758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908232T ATE179885T1 (de) 1992-03-27 1993-03-26 Pharmazeutisches trägersystem, das definierte lipide enthält

Country Status (10)

Country Link
US (1) US5635205A (de)
EP (1) EP0636020B1 (de)
JP (1) JPH07508708A (de)
AT (1) ATE179885T1 (de)
DE (1) DE69324914T2 (de)
DK (1) DK0636020T3 (de)
FI (1) FI114140B (de)
NO (1) NO308984B1 (de)
SE (1) SE9200952D0 (de)
WO (1) WO1993019736A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5665379A (en) * 1990-09-28 1997-09-09 Pharmacia & Upjohn Aktiebolag Lipid particle forming matrix, preparation and use thereof
SE9402453D0 (sv) * 1994-07-12 1994-07-12 Astra Ab New pharmaceutical preparation
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
DE69511418T2 (de) * 1995-10-28 2000-03-30 B. Braun Melsungen Ag Lokalanästhetika und/oder Zentralanalgetika enthaltende pharmazeutische Zusammensetzungen
AU6919598A (en) * 1997-04-17 1998-11-13 Dumex-Alpharma A/S A novel bioadhesive drug delivery system based on liquid crystals
CA2304096C (en) * 1997-09-18 2003-09-09 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
IL140899A0 (en) 1998-07-17 2002-02-10 Skyepharma Inc Lipid/polymer containing pharmaceutical compositions and processes for the preparation thereof
DE69912441T2 (de) 1998-08-19 2004-08-19 Skyepharma Canada Inc., Verdun Injizierbare wässerige propofoldispersionen
DE69825495T2 (de) 1998-12-23 2005-07-28 Idea Ag Verbesserte formulierung zur topischen, nichtinvasiven anwendung in vivo
WO2001001962A1 (en) 1999-07-05 2001-01-11 Idea Ag. A method for the improvement of transport across adaptable semi-permeable barriers
SE0000730D0 (sv) * 2000-03-06 2000-03-06 Scotia Holdings Plc Lipid carrier
AU2002322024B2 (en) * 2001-05-31 2008-05-08 Pacira Pharmaceuticals, Inc. Encapsulation of nanosuspensions in liposomes and microspheres
US20040105881A1 (en) 2002-10-11 2004-06-03 Gregor Cevc Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US8920843B2 (en) * 2007-11-07 2014-12-30 Svip5 Llc Slow release of organic salts of local anesthetics for pain relief
US20140066481A1 (en) * 2010-04-01 2014-03-06 Pharmanest Ab Water-Free Pharmaceutical Compositions Suitable for Local Anaesthetics
EP2846773A4 (de) * 2012-05-10 2015-12-30 Painreform Ltd Depotformulierungen eines lokalanästhetikums und verfahren zur herstellung davon
CN105120839B (zh) * 2013-02-28 2020-07-28 湖州惠中济世生物科技有限公司 可注射长效局麻药半固体制剂及其组成成分
US10220093B2 (en) 2013-02-28 2019-03-05 Mira Pharma Corporation Long-acting semi-solid lipid formulations
US10561606B2 (en) 2017-12-06 2020-02-18 Mira Pharma Corporation Injectable long-acting local anesthetic semi-solid gel formulations
US11426418B2 (en) 2017-12-06 2022-08-30 Mira Pharma Corporation Injectable long-acting semi-solid gel formulations
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
EP4415713A4 (de) 2021-10-14 2025-08-06 Pacira Pharmaceuticals Inc Bupivacain-multivesikuläre liposomformulierungen und verwendungen davon
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
US5059421A (en) * 1985-07-26 1991-10-22 The Liposome Company, Inc. Preparation of targeted liposome systems of a defined size distribution
SE9003100D0 (sv) * 1990-09-28 1990-09-28 Kabivitrum Ab Lipid formulation system

Also Published As

Publication number Publication date
EP0636020A1 (de) 1995-02-01
EP0636020B1 (de) 1999-05-12
NO943543L (no) 1994-09-23
DK0636020T3 (da) 1999-11-15
FI944441A0 (fi) 1994-09-26
SE9200952D0 (sv) 1992-03-27
NO943543D0 (no) 1994-09-23
DE69324914T2 (de) 1999-12-09
NO308984B1 (no) 2000-11-27
US5635205A (en) 1997-06-03
JPH07508708A (ja) 1995-09-28
FI114140B (fi) 2004-08-31
WO1993019736A1 (en) 1993-10-14
FI944441L (fi) 1994-09-26
DE69324914D1 (de) 1999-06-17

Similar Documents

Publication Publication Date Title
ATE179885T1 (de) Pharmazeutisches trägersystem, das definierte lipide enthält
PT83872A (de) Arzneimittel
GR80327B (en) Means for transdermic application of active drug substances
GR1001503B (el) Μέ?οδος δια την παρασκευή φαρμακευτικών ενώσεων αι οποίαι περιέχουν ως δραστική ουσία καρβονικά οξέα τα οποία περιέχουν ?είον κα?ώς και η χρησιμοποίησις αυτών δια την καταπολέμησιν των ρετροιών.
AU5431390A (en) Novel arylpyridazines, their manufacture, use and medicaments containing them
GR3003046T3 (en) Liposome composition
BR9814971A (pt) Sistema para ressuscitação cardiopulmonar assistida para permitir a um resgatador aplicar seu peso corporal ao tórax de uma vìtima, e, uso do mesmo.
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0774959T3 (da) Liposomalt indgivelsessystem for biologisk aktive midler
CA2101101A1 (en) Skin care compositions comprising a retinoid and an imidazole
FI952900A0 (fi) Polypeptidi ja siitä valmistettu anti-HIV-aine
BR9611587A (pt) Processo e composição para tratamento da pele deseres humanos e preparação tópica para aplicação à pele.
MY101784A (en) Novel pharmacological compounds
DE69311541D1 (de) Kosmetische oder pharmazeutische zusammensetzungen zur topischen anwendung die deacylierten glycerophospholipide enthalten
SE8804628D0 (sv) New compounds
KR890005088A (ko) 4- 아미노피리딘 유도체 및 그의 산 부가염
DK0615443T3 (da) Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf
DE69302677D1 (de) Liposomale piroxycam formulierung
ES2086538T3 (es) Medicamento para el tratamiento de la hiperlipemia y/o aterosclerosis.
FR2362849A1 (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
DE69112573D1 (de) Immunstimulierendes arzneimittel, das polare glycopeptidolipide von mycobakterium-chelonae enthält.
SE8302580L (sv) Substituerade iminoderivat av dihydrobensopyran och dihydrobensotiopyran och forfarande for deras framstellning
ES2122962T3 (es) Derivados de alquileno-dioxibenceno opticamente activos y su uso en terapia.
MX9205385A (es) Perhidro-1-h-pirido(1,2-a)piracinas 2-sustituidas neurolepticas.
CO4600680A1 (es) Procedimientos para la prevencion de la degradacion de la proteina c

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
EEIH Change in the person of patent owner
REN Ceased due to non-payment of the annual fee